Ikuo Yana

3.1k total citations
30 papers, 2.6k citations indexed

About

Ikuo Yana is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Ikuo Yana has authored 30 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 19 papers in Cancer Research and 8 papers in Molecular Biology. Recurrent topics in Ikuo Yana's work include Protease and Inhibitor Mechanisms (16 papers), Peptidase Inhibition and Analysis (10 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Ikuo Yana is often cited by papers focused on Protease and Inhibitor Mechanisms (16 papers), Peptidase Inhibition and Analysis (10 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Ikuo Yana collaborates with scholars based in Japan, United States and France. Ikuo Yana's co-authors include Stephen J. Weiss, Motoharu Seiki, Kevin B. Hotary, Edward Allen, Antonello Punturieri, Yoshifumi Itoh, Hiroshi Ohno, Takamasa Uekita, Xiaoyan Li and Farideh Sabeh and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The Journal of Cell Biology.

In The Last Decade

Ikuo Yana

30 papers receiving 2.6k citations

Peers

Countries citing papers authored by Ikuo Yana

Since Specialization

Citations

This map shows the geographic impact of Ikuo Yana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ikuo Yana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ikuo Yana more than expected).

Fields of papers citing papers by Ikuo Yana

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ikuo Yana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ikuo Yana. The network helps show where Ikuo Yana may publish in the future.

Co-authorship network of co-authors of Ikuo Yana

This figure shows the co-authorship network connecting the top 25 collaborators of Ikuo Yana. A scholar is included among the top collaborators of Ikuo Yana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ikuo Yana. Ikuo Yana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A prospective, multicenter, clinical study of duodenoscope contamination after reprocessing 2022 ·Infection Control and Hospital Epidemiology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ikuo Yana, (unknown), Lionel Pineau, Michelle J. Alfa	14
2	Feasibility of Cisplatin/5-Fluorouracil and Panitumumab in Japanese Patients with Squamous Cell Carcinoma of the Head and Neck 2014 ·Japanese Journal of Clinical Oncology ·Makoto Tahara, Yusuke Onozawa, Hirofumi Fujii, Nobuya Monden, Ikuo Yana, Satoru Otani, Yasuhisa Hasegawa	3
3	Panitumumab in Japanese Patients with Unresectable Colorectal Cancer: A Post-marketing Surveillance Study of 3085 Patients† 2014 ·Japanese Journal of Clinical Oncology ·Narikazu Boku, Kenichi Sugihara, Yuko Kitagawa, Kiyohiko Hatake, Akihiko Gemma, Naoya Yamazaki, Kei Muro, Tetsuya Hamaguchi, Takayuki Yoshino, Ikuo Yana, Hiroshi Ueno, Atsushi Ohtsu	21
4	The role of MT2-MMP in cancer progression 2010 ·Biochemical and Biophysical Research Communications ·Emiko Ito, Ikuo Yana, (unknown), (unknown), Maki Takeda, (unknown), Seiji Mori, Yoshinosuke Hamada, Naomasa Kawaguchi, Nariaki Matsuura∥	26
5	Molecular Dissection of the Structural Machinery Underlying the Tissue-invasive Activity of Membrane Type-1 Matrix Metalloproteinase 2008 ·Molecular Biology of the Cell ·Xiaoyan Li, Ichiro Ota, Ikuo Yana, Farideh Sabeh, Stephen J. Weiss	99
6	Negative Regulation of Osteoclastogenesis by Ectodomain Shedding of Receptor Activator of NF-κB Ligand 2006 ·Journal of Biological Chemistry ·Atsuhiko Hikita, Ikuo Yana, Hidetoshi Wakeyama, Masaki Nakamura, Yuho Kadono, Yasushi Oshima, Kozo Nakamura, Motoharu Seiki, Sakae Tanaka	186
7	Competitive disruption of the tumor-promoting function of membrane type 1 matrix metalloproteinase/matrix metalloproteinase-14 in vivo 2005 ·Molecular Cancer Therapeutics ·Takahiro Nonaka, (unknown), Yoshifumi Itoh, Ikuo Yana, Motoharu Seiki	34
8	Role of pericellular proteolysis by membrane-type 1 matrix metalloproteinase in cancer invasion and angiogenesis 2003 ·Cancer and Metastasis Reviews ·Motoharu Seiki, Naohiko Koshikawa, Ikuo Yana	95
9	Roles of pericellular proteolysis by membrane type‐1 matrix metalloproteinase in cancer invasion and angiogenesis 2003 ·Cancer Science ·Motoharu Seiki, Ikuo Yana	127
10	Absence of mechanical allodynia and Aβ‐fiber sprouting after sciatic nerve injury in mice lacking membrane‐type 5 matrix metalloproteinase 2003 ·FEBS Letters ·(unknown), Takahiro Nonaka, Akiko Okada, Hiroaki Kinoh, Hiromi Hayashita‐Kinoh, Nobuaki Yoshida, Ikuo Yana, Motoharu Seiki	60
11	Clusterin, an Abundant Serum Factor, Is a Possible Negative Regulator of MT6-MMP/MMP-25 Produced by Neutrophils 2003 ·Journal of Biological Chemistry ·Akira Matsuda, Yoshifumi Itoh, Naohiko Koshikawa, Toshifumi Akizawa, Ikuo Yana, Motoharu Seiki	51
12	CD44 directs membrane-type 1 matrix metalloproteinase (MT1-MMP) to lamellipodia by associating with its hemopexin-like domain (PEX) 2002 ·Molecular Biology of the Cell ·Hiroyuki Mori, (unknown), Naohiko Koshikawa, Masahiro Kajita, Yoshifumi Itoh, Hiroki Sato, Hideaki Tojo, Ikuo Yana, Motoharu Seiki	2
13	MT-MMPs play pivotal roles in cancer dissemination 2002 ·Clinical & Experimental Metastasis ·Ikuo Yana, Motoharu Seiki	72
14	Regulation of Membrane Type-1 Matrix Metalloproteinase Activation by Proprotein Convertases 2000 ·Molecular Biology of the Cell ·Ikuo Yana, Stephen J. Weiss	257
15	A detailed analysis of the role of K-ras gene mutation in the progression of colorectal adenoma 1997 ·British Journal of Cancer ·Tadashi Ohnishi, Naohiro Tomita, Takushi Monden, Masayuki Ohue, Ikuo Yana, Kaoru Takami, Hirofumi Yamamoto, (unknown), Nobuteru Kikkawa, Takashi Shimano, Morito Monden	40
16	Frequent loss of heterozygosity at telomeric loci on 22q in sporadic colorectal cancers 1995 ·International Journal of Cancer ·Ikuo Yana, Hiroki Kurahashi, Shoji Nakamori, Masao Kameyama, Tsutomu Nakamura, Motohisa Takami, Takesada Mori, Shin‐ichiro Takai, Isamu Nishisho	35
17	Clinicopathological findings and p53 expression of thyroid cancer in children 1995 ·Surgery Today ·Tetsuro Kobayashi, Hiroyuki Nakanishi, Ikuo Yana, Isamu Nishisho, (unknown), (unknown), Tsutomu Takeda, Takesada Mori	1
18	Refined mapping of eight cosmid markers on human chromosome 22 1994 ·The Japanese Journal of Human Genetics ·Hiroki Kurahashi, (unknown), Ikuo Yana, Thomas Melot, Olivier Delattre, Gilles Thomas, Shintaro Okada, (unknown), Isamu Nishisho	2
19	p53 Gene Mutations Associated with Anaplastic Transformation of Human Thyroid Carcinomas 1992 ·Japanese Journal of Cancer Research ·(unknown), Ikuo Yana, Tetsuro Kobayashi, Eisei Shin, (unknown), Shoichi Fujita, Akihiro Miya, Takesada Mori, Isamu Nishisho, Shin‐ichiro Takai	115
20	Inactivation of the p53 Gene Is not Required for Tumorigenesis of Medullary Thyroid Carcinoma or Pheochromocytoma 1992 ·Japanese Journal of Cancer Research ·Ikuo Yana, (unknown), Eisei Shin, (unknown), Hiroki Kurahashi, (unknown), Tetsuro Kobayashi, Takesada Mori, Isamu Nishisho, Shin‐ichiro Takai	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact